In 2009 the Nobel Prize in Physiology was awarded for the discovery of the roles telomeres and the related enzyme telomerase play in the protection of DNA.

During cell division, DNA must be copied accurately from end-to-end. When portions of the Telomere endcaps are missing, DNA shortens as entire sections of the genetic code are cut off. This degradation of genetic material leads to aging and age-related diseases processes.

Telomir 1 is the only known drug in the world that modulates telomerase to promote the repair and lengthening telomeres, thus restoring the possibility of high fidelity, accurate replication of DNA.

Telomir 1 is under investigation to potentially provide a therapeutic intervention against age-related inflammatory conditions. It is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal.